SIGA’s CEO, Dr. Phillip Gomez, and Garrett Ingram, President, CEO of Cipla Therapeutics, discuss the companies’ recently announced collaboration to provide the U.S. government[...]

SIGA's CEO, Dr. Phillip Gomez, and Garrett Ingram, President, CEO of Cipla Therapeutics, discuss the companies' recently announced collaboration to provide the U.S. government with solutions for its biothreat and public health needs, with a focus on tackling antimicrobial resistance

June 10, 2021